IMMUNOHISTOLOGICAL RELATION BETWEEN DR ANTIGEN EXPRESSION ON MELANOMA-CELLS AND INFILTRATION BY CD8+ T-CELLS

被引:13
作者
HERSEY, P
JAMAL, O
机构
[1] Immunology and Oncology Unit, Mater Misericordiae Hospital, Royal Newcastle Hospital, Newcastle, NSW, David Maddison Clinical Sciences Building
基金
英国医学研究理事会;
关键词
D O I
10.3109/00313029009063551
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Previous studies have suggested that class II major histocompatibility (MHC) antigen expression on melanoma cells may influence immune responses against melanoma and the nature of lymphocytic infiltrates against the tumor. This question was examined further by immunoperoxidase studies on sections from 29 primary and 30 metastatic melanoma with monoclonal antibodies (MAbs) against different lymphocyte subsets. The results indicated that expression of MHC class II DR* antigens on melanoma cells was associated with increased overall lymphocytic infiltration and that this applied particularly to the CD-epsilon + subset of T cells. The CR3 receptor (CD 11b) was expressed predominantly on T cells and not macrophages but infiltration by CD11b + cells did not correlate strongly with DR expression on melanoma cells. Dual staining with MAbs to CD8 and CD11b revealed that, whereas most of the CD8 + cells in DR - primary melanoma and DR + metastatic melanoma were CD11b +, only approximately 50% of the CD8 + cells in DR + primary melanoma were also CD11b +. Expression of CD11b on T cells was reported to define a suppressor subset of T cells. If the latter is correct the present results suggest that DR expression on primary melanoma is associated with infiltration by the cytotoxic T cell subset, whereas in the absence of DR antigens and in metastases this subset is absent and the predominant subset appears to be CD8 + CD11b + T cells with suppressor activity. The biologic and prognostic significance of these findings remains to be determined.
引用
收藏
页码:133 / 139
页数:7
相关论文
共 30 条
[11]  
CLEMENT LT, 1984, J IMMUNOL, V133, P2461
[12]   PRIMARY BUT NOT METASTATIC HUMAN MELANOMAS EXPRESSING DR ANTIGENS STIMULATE AUTOLOGOUS LYMPHOCYTES [J].
FOSSATI, G ;
TARAMELLI, D ;
BALSARI, A ;
BOGDANOVICH, G ;
ANDREOLA, S ;
PARMIANI, G .
INTERNATIONAL JOURNAL OF CANCER, 1984, 33 (05) :591-597
[13]   INFILTRATING MONONUCLEAR-CELLS IN HUMAN-BREAST CARCINOMA - PREDOMINANCE OF T4+-MONOCYTIC CELLS IN THE TUMOR STROMA [J].
GOTTLINGER, HG ;
RIEBER, P ;
GOKEL, JM ;
LOHE, KJ ;
RIETHMULLER, G .
INTERNATIONAL JOURNAL OF CANCER, 1985, 35 (02) :199-205
[14]   HLA-DR HISTOCOMPATIBILITY LEUKOCYTE ANTIGENS PERMIT CULTURED HUMAN-MELANOMA CELLS FROM EARLY BUT NOT ADVANCED DISEASE TO STIMULATE AUTOLOGOUS LYMPHOCYTES [J].
GUERRY, D ;
ALEXANDER, MA ;
HERLYN, MF ;
ZEHNGEBOT, LM ;
MITCHELL, KF ;
ZMIJEWSKI, CM ;
LUSK, EJ .
JOURNAL OF CLINICAL INVESTIGATION, 1984, 73 (01) :267-271
[15]   TUMOR THICKNESS AND LYMPHOCYTIC INFILTRATION IN MALIGNANT-MELANOMA OF HEAD AND NECK [J].
HANSEN, MG ;
MCCARTEN, AB .
AMERICAN JOURNAL OF SURGERY, 1974, 128 (04) :557-561
[16]   EXPRESSION OF THE GANGLIOSIDES GD3 AND GD2 ON LYMPHOCYTES IN TISSUE-SECTIONS OF MELANOMA [J].
HERSEY, P ;
JAMAL, O .
PATHOLOGY, 1989, 21 (01) :51-58
[17]   CURRENT RESEARCH ON IMMUNOPATHOLOGY OF MELANOMA - ANALYSIS OF LYMPHOCYTE POPULATIONS IN RELATION TO ANTIGEN EXPRESSION AND HISTOLOGICAL FEATURES OF MELANOMA [J].
HERSEY, P ;
MURRAY, E ;
GRACE, J ;
MCCARTHY, WH .
PATHOLOGY, 1985, 17 (03) :385-391
[18]   A COMPARATIVE-STUDY OF THE PEROXIDASE-ANTIPEROXIDASE METHOD AND AN AVIDIN-BIOTIN COMPLEX METHOD FOR STUDYING POLYPEPTIDE HORMONES WITH RADIOIMMUNOASSAY ANTIBODIES [J].
HSU, SM ;
RAINE, L ;
FANGER, H .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1981, 75 (05) :734-738
[19]   THE MULTIFUNCTIONAL ROLE OF C-3, THE 3RD COMPONENT OF COMPLEMENT [J].
LAMBRIS, JD .
IMMUNOLOGY TODAY, 1988, 9 (12) :387-393
[20]  
LARSEN TE, 1978, ACTA PATH MICRO IM A, V86, P523